We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+5.11%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$6.17B
AUM Growth
-$913M
Cap. Flow
-$1.4B
Cap. Flow %
-22.63%
Top 10 Hldgs %
19%
Holding
2,566
New
82
Increased
1,020
Reduced
624
Closed
121

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$11.2M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$8.52M
3
T icon
AT&T
T
+$4.71M
4
BIIB icon
Biogen
BIIB
+$4.13M
5
TWTR
Twitter, Inc.
TWTR
+$3.99M

Sector Composition

Rank Sector Weight
1 Technology 15.07%
2 Financials 12.9%
3 Healthcare 10.59%
4 Industrials 9.17%
5 Consumer Discretionary 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRDM icon
1301
Iridium Communications
IRDM
$5.26B
$501K 0.01%
31,111
+5,844
+23% +$79.5K
MGRC icon
1302
McGrath RentCorp
MGRC
$2.94B
$500K 0.01%
7,908
HLI icon
1303
Houlihan Lokey
HLI
$9.24B
$500K 0.01%
9,762
+1,209
+14% +$57.8K
TAHO
1304
DELISTED
Tahoe Resources Inc
TAHO
$499K 0.01%
101,488
+92,561
+1,037% +$466K
MYOK
1305
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$499K 0.01%
10,050
+3,466
+53% +$168K
ALKS icon
1306
Alkermes
ALKS
$8.44B
$499K 0.01%
12,116
+734
+6% +$33.4K
OPK icon
1307
Opko Health
OPK
$1.04B
$498K 0.01%
106,050
+94,799
+843% +$360K
PTCT icon
1308
PTC Therapeutics
PTCT
$6.06B
$498K 0.01%
14,769
+1,753
+13% +$54.7K
EXEL icon
1309
Exelixis
EXEL
$12.5B
$497K 0.01%
23,103
+1,262
+6% +$26.1K
EPAM icon
1310
EPAM Systems
EPAM
$5.17B
$497K 0.01%
3,995
-11,705
-75% -$1.41M
PK icon
1311
Park Hotels & Resorts
PK
$2.99B
$496K 0.01%
16,207
+227
+1% +$6.78K
ZGNX
1312
DELISTED
Zogenix, Inc.
ZGNX
$495K 0.01%
11,189
ARCH
1313
DELISTED
Arch Resources, Inc.
ARCH
$494K 0.01%
6,304
-4,935
-44% -$420K
VTLE
1314
DELISTED
Vital Energy
VTLE
$494K 0.01%
2,568
+1,962
+324% +$368K
ACAD icon
1315
Acadia Pharmaceuticals
ACAD
$5.07B
$494K 0.01%
32,357
+25,015
+341% +$446K
WBC
1316
DELISTED
WABCO HOLDINGS INC.
WBC
$493K 0.01%
4,216
+433
+11% +$55.1K
PE
1317
DELISTED
PARSLEY ENERGY INC
PE
$493K 0.01%
16,273
+2,426
+18% +$71.5K
BLUE
1318
DELISTED
bluebird bio
BLUE
$492K 0.01%
242
-940
-80% -$2.14M
STBA icon
1319
S&T Bancorp
STBA
$1.82B
$491K 0.01%
11,360
ATRA icon
1320
Atara Biotherapeutics
ATRA
$83.1M
$489K 0.01%
532
+108
+25% +$116K
BWXT icon
1321
BWX Technologies
BWXT
$15.8B
$488K 0.01%
7,836
+641
+9% +$42.6K
DMC
1322
Del Monte Corp
DMC
$1.42B
$487K 0.01%
10,942
+1,384
+14% +$64.7K
CORT icon
1323
Corcept Therapeutics
CORT
$12.1B
$487K 0.01%
30,977
+607
+2% +$10.6K
AIR icon
1324
AAR Corp
AIR
$5.96B
$486K 0.01%
10,453
+366
+4% +$16.7K
BUSE icon
1325
First Busey Corp
BUSE
$2.58B
$486K 0.01%
15,315
+2,205
+17% +$68.9K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2018 Portfolio in Review

As of Q2 2018, Metropolitan Life Insurance Company (MetLife) held 2,566 positions worth $6.17B, down 13% from $7.08B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $1.4B in Q2 2018, closing 121 positions and reducing 624 holdings. Its most notable exit was Brighthouse Financial, an estimated $1.19B position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in NII Holdings, Inc. Common Stock worth $119K.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2018 buy was NII Holdings, Inc. Common Stock: 778,252 shares worth $119K.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Russell 2000 ETF in Q2 2018, an estimated $11.2M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2018 reduction was Bank of America, cutting an estimated $22.7M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Brighthouse Financial in Q2 2018, selling an estimated $1.19B.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 19% of its $6.17B portfolio in Q2 2018.
  • Metropolitan Life Insurance Company (MetLife) opened 82 new positions and closed 121 in Q2 2018.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 13% quarter-over-quarter to $6.17B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2018, filed 15 Aug 2018.